| Starts: | Tuesday March 31, 2009 at 10:00am |
|---|---|
| Ends: | Tuesday March 31, 2009 at 11:30am |
| Event Type: | Training/Seminar |
| Location: | This is a virtual event. |
| Price: | |
| Website: | http://www.complianceonline.com/ecommerce/control/trainingFocus?product_id=701186&channel=lkd |
| Industry: | biotechnology |
| Keywords: | Biopharmaceutical, C Gmp, 21 Cfr210, 21 Cfr211, Pharmaceutical |
| Intended For: | # Senior Management responsible for making final decisions # QA directors and managers # Microbiology analysts and technicians # Regulatory and Compliance Management # Consultants # Quality system auditors |
| Organization: | ComplianceOnline |
Pharmaceutical and biopharmaceutical companies must operate under cGMPs as described in the predicate regulations, 21CFR210 and 21CFR211, in order to sell their products to the public. A forgotten aspect of GMPs is that they were written to prevent contamination of products. Therefore, the microbiological wellness of a facility is a critical attribute that auditors examine to determine whether or not a facility is cGMP compliant. This webinar will outline actions to take to ensure the microbiological wellness of your facility and will introduce the concept of "Thinking like a Bug" that will help your company operate in a manner which prevents and eliminates microbial excursions, enabling you to comply with cGMPs and also save money.